Yayın:
Study of bacteria isolated from COVID-19 and non-COVID-19 intensive care units and determination of their antibiotic susceptibility profiles

Basit Görünüm
dc.contributor.authorKilinç, Çetin
dc.contributor.authorCoplu, Nilay
dc.contributor.authorYaşar Duman, Melike
dc.contributor.authorÇalişir, Büşra
dc.contributor.authorTüfekci̇, Enis Fuat
dc.contributor.authorGülhan, Muhammet
dc.contributor.authorYilmaz, Ayşe
dc.contributor.authorSoylu, Veysel Garani
dc.date.accessioned2026-01-04T17:23:18Z
dc.date.issued2022-10-29
dc.description.abstractNosocomial infections are infections that occur 48-72 hours after hospitalization, especially caused by bacteria, and pose a high risk for patients in the intensive care units (ICUs), including Covid-ICU. This study was aimed to reveal the distribution and antibiotic susceptibility profiles of bacteria isolated from various clinical samples of non-Covid-ICU and Covid-ICU patients. Bacterial strains isolated from ICUs patients in Kastamonu Training and Research Hospital between March 2020 and October 2020 were included in this study. The identification of the strains was carried out using the Vitek 2 compact automated system (BioMerieux, France) as well as standard microbiological methods. Antibiotic susceptibility tests were studied using the Vitek 2 automated system and the results were interpreted based on the European Committee for Antimicrobial Susceptibility Tests (EUCAST) guideline. There were 302 patients in the non-Covid-ICU and 440 patients in the Covid-ICU. A total of 470 strains, 370 from non-Covid-ICU and 100 from Covid-ICU, were isolated. Acinetobacter spp was the most frequently isolated species for both ICUs. Acinetobacter spp isolated from non-Covid-ICU had higher resistance rates to meropenem (p= 0.043), ceftazidime (p= 0.014), and levofloxacin (p=
dc.description.urihttps://doi.org/10.52142/omujecm.39.4.20
dc.description.urihttps://avesis.uludag.edu.tr/publication/details/af733292-1b72-4be1-9a12-de7a32f69d52/oai
dc.description.urihttps://dergipark.org.tr/tr/pub/omujecm/issue/73188/1099585
dc.identifier.doi10.52142/omujecm.39.4.20
dc.identifier.eissn1309-5129
dc.identifier.endpage1031
dc.identifier.issn1309-4483
dc.identifier.openairedoi_dedup___::a20e58857e11384b0960c54789d6d349
dc.identifier.scopus2-s2.0-85142037327
dc.identifier.startpage1027
dc.identifier.urihttps://hdl.handle.net/20.500.12597/40089
dc.identifier.volume39
dc.publisherOndokuzmayis University, Faculty of Medicine
dc.relation.ispartofJournal of Experimental and Clinical Medicine
dc.rightsCLOSED
dc.subjectHealth Care Administration
dc.subjectSağlık Kurumları Yönetimi
dc.subjectAcinetobacter
dc.subjectantibiotic resistance
dc.subjectCovid-intensive care unit
dc.subjectnosocomial infections
dc.subject.sdg3. Good health
dc.titleStudy of bacteria isolated from COVID-19 and non-COVID-19 intensive care units and determination of their antibiotic susceptibility profiles
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"KILINÇ, Çetin","name":"Çetin","surname":"Kilinç","rank":1,"pid":null},{"fullName":"COPLU, Nilay","name":"Nilay","surname":"Coplu","rank":2,"pid":null},{"fullName":"YAŞAR DUMAN, Melike","name":"Melike","surname":"Yaşar Duman","rank":3,"pid":null},{"fullName":"ÇALIŞIR, Büşra","name":"Büşra","surname":"Çalişir","rank":4,"pid":null},{"fullName":"TÜFEKCİ, Enis Fuat","name":"Enis Fuat","surname":"Tüfekci̇","rank":5,"pid":null},{"fullName":"GÜLHAN, Muhammet","name":"Muhammet","surname":"Gülhan","rank":6,"pid":null},{"fullName":"YILMAZ, Ayşe","name":"Ayşe","surname":"Yilmaz","rank":7,"pid":null},{"fullName":"SOYLU, Veysel Garani","name":"Veysel Garani","surname":"Soylu","rank":8,"pid":null}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"und","label":"Undetermined"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Health Care Administration"},"provenance":null},{"subject":{"scheme":"keyword","value":"Sağlık Kurumları Yönetimi"},"provenance":null},{"subject":{"scheme":"keyword","value":"Acinetobacter;antibiotic resistance;Covid-intensive care unit;nosocomial infections"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Study of bacteria isolated from COVID-19 and non-COVID-19 intensive care units and determination of their antibiotic susceptibility profiles","subTitle":null,"descriptions":["Nosocomial infections are infections that occur 48-72 hours after hospitalization, especially caused by bacteria, and pose a high risk for patients in the intensive care units (ICUs), including Covid-ICU. This study was aimed to reveal the distribution and antibiotic susceptibility profiles of bacteria isolated from various clinical samples of non-Covid-ICU and Covid-ICU patients. Bacterial strains isolated from ICUs patients in Kastamonu Training and Research Hospital between March 2020 and October 2020 were included in this study. The identification of the strains was carried out using the Vitek 2 compact automated system (BioMerieux, France) as well as standard microbiological methods. Antibiotic susceptibility tests were studied using the Vitek 2 automated system and the results were interpreted based on the European Committee for Antimicrobial Susceptibility Tests (EUCAST) guideline. There were 302 patients in the non-Covid-ICU and 440 patients in the Covid-ICU. A total of 470 strains, 370 from non-Covid-ICU and 100 from Covid-ICU, were isolated. Acinetobacter spp was the most frequently isolated species for both ICUs. Acinetobacter spp isolated from non-Covid-ICU had higher resistance rates to meropenem (p= 0.043), ceftazidime (p= 0.014), and levofloxacin (p="],"publicationDate":"2022-10-29","publisher":"Ondokuzmayis University, Faculty of Medicine","embargoEndDate":null,"sources":["Crossref","Volume: 39, Issue: 4 1027-1031","1309-4483","1309-5129","Journal of Experimental and Clinical Medicine"],"formats":["application/pdf"],"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Journal of Experimental and Clinical Medicine","issnPrinted":"1309-4483","issnOnline":"1309-5129","issnLinking":null,"ep":"1031","iss":null,"sp":"1027","vol":"39","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::a20e58857e11384b0960c54789d6d349","originalIds":["10.52142/omujecm.39.4.20","50|doiboost____|a20e58857e11384b0960c54789d6d349","50|od______9458::05566b5c5dd75b42a4529704910cd54b","af733292-1b72-4be1-9a12-de7a32f69d52","oai:dergipark.org.tr:article/1099585","50|tubitakulakb::8cda0c44dce17746fd414ab2e44424c3"],"pids":[{"scheme":"doi","value":"10.52142/omujecm.39.4.20"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":0,"influence":2.5349236e-9,"popularity":1.8548826e-9,"impulse":0,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.52142/omujecm.39.4.20"}],"type":"Article","urls":["https://doi.org/10.52142/omujecm.39.4.20"],"publicationDate":"2022-10-29","refereed":"peerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.52142/omujecm.39.4.20"}],"type":"Article","urls":["https://avesis.uludag.edu.tr/publication/details/af733292-1b72-4be1-9a12-de7a32f69d52/oai"],"publicationDate":"2022-10-01","refereed":"nonPeerReviewed"},{"type":"Article","urls":["https://dergipark.org.tr/tr/pub/omujecm/issue/73188/1099585"],"publicationDate":"2022-04-06","refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atScopus

Dosyalar

Koleksiyonlar

Publications